Facebook Twitter YouTube  
Contact Us
Search Clinical Trials
Home > Clinical Trials & Research > Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Disease/Condition   Infectious Disease,Pediatric Studies
Eligibility Criteria   Ages Eligible for Study: 3 Years to 17 Years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Principal Investigator   Debra Pan, MD
Contact Name   Marc Scullin
Phone   (718) 920-4774
Contact Email   marc.scullin@einstein.yu.edu
Protocol Number   OCT12-0208; IRB# 12-10-265
Status   Enrolling